Search

Author/Creator Beaver, Julia A.

1. A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations. Issue 2 (28th December 2014)

Authors:
Blair, Brian G.; Wu, Xinyan; Zahari, Muhammad Saddiq; Mohseni, Morassa; Cidado, Justin; Wong, Hong Yuen; Beaver, Julia A.; Cochran, Rory L.; Zabransky, Daniel J.; Croessmann, Sarah; Chu, David; Toro, Patricia Valda; Cravero, Karen; Pandey, Akhilesh; Park, Ben Ho; Pandey, Akhilesh; Moran, Michael F.
Journal:
Proteomics
Issue:
Volume 15:Issue 2/3(2015)
Page Start:
318
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Addressing Barriers to Clinical Trial Participation for Transgender People With Cancer to Improve Access and Generate Data. Issue 10 (1st April 2023)

Authors:
Alpert, Ash B.; Brewer, Jamie Renee; Adams, Spencer; Rivers, Lexis; Orta, Sunshine; Blosnich, John R.; Miedlich, Susanne; Kamen, Charles; Dizon, Don S.; Pazdur, Richard; Beaver, Julia A.; Fashoyin-Aje, Lola
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 10(2023)
Page Start:
1825
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer. Issue 11 (10th April 2022)

Authors:
Royce, Melanie; Osgood, Christy; Mulkey, Flora; Bloomquist, Erik; Pierce, William F.; Roy, Arpita; Kalavar, Shyam; Ghosh, Soma; Philip, Reena; Rizvi, Fatima; Mixter, Bronwyn D.; Tang, Shenghui; Pazdur, Richard; Beaver, Julia A.; Amiri-Kordestani, Laleh
Journal:
Journal of clinical oncology
Issue:
Volume 40:Issue 11(2022)
Page Start:
1155
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum‐Based Chemotherapy in Extensive Stage Small Cell Lung Cancer. (25th March 2021)

Authors:
Mathieu, Luckson; Shah, Sujay; Pai‐Scherf, Lee; Larkins, Erin; Vallejo, Jonathon; Li, Xiaoxue; Rodriguez, Lisa; Mishra‐Kalyani, Pallavi; Goldberg, Kirsten B.; Kluetz, Paul G.; Theoret, Marc R.; Beaver, Julia A.; Pazdur, Richard; Singh, Harpreet
Journal:
Oncologist
Issue:
Volume 26:Number 5(2021)
Page Start:
433
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing Chemotherapy. (12th December 2018)

Authors:
Suzman, Daniel L.; Agrawal, Sundeep; Ning, Yang‐min; Maher, V. Ellen; Fernandes, Laura L.; Karuri, Stella; Tang, Shenghui; Sridhara, Rajeshwari; Schroeder, Jason; Goldberg, Kirsten B.; Ibrahim, Amna; McKee, Amy E.; Pazdur, Richard; Beaver, Julia A.
Journal:
Oncologist
Issue:
Volume 24:Number 4(2019)
Page Start:
563
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer. (20th October 2020)

Authors:
Arora, Shaily; Balasubramaniam, Sanjeeve; Zhang, Hui; Berman, Tara; Narayan, Preeti; Suzman, Daniel; Bloomquist, Erik; Tang, Shenghui; Gong, Yutao; Sridhara, Rajeshwari; Turcu, Francisca Reyes; Chatterjee, Deb; Saritas‐Yildirim, Banu; Ghosh, Soma; Philip, Reena; Pathak, Anand; Gao, Jennifer J.; A...
Journal:
Oncologist
Issue:
Volume 26:Number 1(2021)
Page Start:
e164
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗